These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38964956)

  • 1. Corrigendum to "Cellular landscaping of cisplatin resistance in cervical cancer" Biomed. Pharmacother. 153(2022) 113345.
    Bhattacharjee R; Dey T; Kumar L; Kar S; Sarkar R; Ghorai M; Malik S; Jha NK; Vellingiri B; Kesari KK; Pérez de la Lastra JM; Dey A
    Biomed Pharmacother; 2024 Aug; 177():117097. PubMed ID: 38964956
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression" [Biomed. Pharmacother. 115 (2019) 108869].
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2020 Feb; 122():109789. PubMed ID: 31864836
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells" [Biomed. Pharmacother. 122 (2020) 109654].
    Wang Z; Wang W; Zhao W; Wang Z; Yang J; Wang W; Teng P; Su X; Li D; Zhang X; Wang H; Hao M
    Biomed Pharmacother; 2020 May; 125():109981. PubMed ID: 32067843
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice" [Biomed. Pharmacother. 110 (2019) 95-104].
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Jun; 114():108827. PubMed ID: 30954310
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213].
    Cao L; Wang S; Zhang L; Li J
    Biomed Pharmacother; 2023 Apr; 160():114280. PubMed ID: 36725470
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790].
    Cai H; Yan L; Liu N; Xu M; Cai H
    Biomed Pharmacother; 2020 Jun; 126():110077. PubMed ID: 32173085
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer" [Biomed. Pharmacother. 117 (2019) 109072].
    Li X; Wu X; Yang H; Li L; Ye Z; Rao Y
    Biomed Pharmacother; 2023 Sep; 165():115182. PubMed ID: 37474405
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells" [Biomed. Pharmacother. 90 (2017) 906-913].
    Soni N; Jyoti K; Jain UK; Katyal A; Chandra R; Madan J
    Biomed Pharmacother; 2018 Sep; 105():1360. PubMed ID: 29929878
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy" [Biomed. Pharmacother. 173 (2024) 116363].
    Khan F; Pandey P; Verma M; Ramniwas S; Lee D; Moon S; Park MN; Upadhyay TK; Kim B
    Biomed Pharmacother; 2024 Jul; 176():116756. PubMed ID: 38824000
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281].
    Wu J; Shuang Z; Zhao J; Tang H; Liu P; Zhang L; Xie X; Xiao X
    Biomed Pharmacother; 2020 Jul; 127():110174. PubMed ID: 32423656
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer" [Biomed. Pharmacother. 174 (2024) 116497].
    Ahmed KR; Rahman MM; Islam MN; Fahim MMH; Rahman MA; Kim B
    Biomed Pharmacother; 2024 Jul; 176():116757. PubMed ID: 38797597
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular landscaping of cisplatin resistance in cervical cancer.
    Bhattacharjee R; Dey T; Kumar L; Kar S; Sarkar R; Ghorai M; Malik S; Jha NK; Vellingiri B; Kesari KK; Pérez de la Lastra JM; Dey A
    Biomed Pharmacother; 2022 Sep; 153():113345. PubMed ID: 35810692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy" [Biomed. Pharmacother. 139 (2021) 111550].
    Awadasseid A; Ma X; Wu Y; Zhang W
    Biomed Pharmacother; 2022 Apr; 148():112764. PubMed ID: 35241323
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Intrinsic β-catenin signaling suppresses CD8
    Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
    Biomed Pharmacother; 2020 Dec; 132():110828. PubMed ID: 33053510
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "New insights into long non-coding RNAs in non-small cell lung cancer" [Biomed. Pharmacother. 131 (November) (2020) 110775].
    Ye R; Tang R; Gan S; Li R; Cheng Y; Guo L; Sun Y; Zeng C
    Biomed Pharmacother; 2020 Dec; 132():110930. PubMed ID: 33254435
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies" [Biomed. Pharmacother. 161 (2023) 114491].
    Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
    Biomed Pharmacother; 2023 Nov; 167():115388. PubMed ID: 37741799
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy" [Biomed. Pharmacother. 120 (2019) 109519].
    Wang N; Yang B; Muhetaer G; Wang S; Zheng Y; Lu J; Li M; Zhang F; Situ H; Lin Y; Wang Z
    Biomed Pharmacother; 2022 May; 149():112867. PubMed ID: 35370022
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to: "Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death" [Biomed. Pharmacother. 153 (2022) 113511].
    Liu L; An X; Schaefer M; Yan B; de la Torre C; Hillmer S; Gladkich J; Herr I
    Biomed Pharmacother; 2023 Dec; 169():115879. PubMed ID: 37973469
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2020 Mar; 123():109823. PubMed ID: 31959384
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127].
    Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
    Biomed Pharmacother; 2018 Mar; 99():1033-1036. PubMed ID: 29398246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.